During the past decade, Rush-Copley Cancer Care Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 56 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush-Copley Cancer Care Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 61 trials, followed by "Eastern Cooperative Oncology Group" with 28 trials sponsored, "SWOG Cancer Research Network" with 18 trials sponsored, "Gynecologic Oncology Group" with 6 trials sponsored and "NSABP Foundation Inc" with 6 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush-Copley Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 134 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Rush-Copley Cancer Care Center" are "Breast Cancer" (29 trials), "Lung Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (13 trials) and "Leukemia" (9 trials). Many other conditions were trialed in "Rush-Copley Cancer Care Center" in a lesser frequency.

Most popular intervention types in "Rush-Copley Cancer Care Center" are "Drug" (106 trials), "Biological" (43 trials), "Other" (37 trials), "Radiation" (23 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (26 trials), "carboplatin" (14 trials), "cisplatin" (13 trials), "radiation therapy" (13 trials) and "paclitaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "Rush-Copley Cancer Care Center" are 104 trials for "All" genders, 25 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Rush-Copley Cancer Care Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 116 completed trials in Rush-Copley Cancer Care Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Rush-Copley Cancer Care Center, 2 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".